Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anat Amir is active.

Publication


Featured researches published by Anat Amir.


Proceedings of the National Academy of Sciences of the United States of America | 2009

Peptides modulating conformational changes in secreted chaperones: From in silico design to preclinical proof of concept

Yossef Kliger; Ofer Levy; Anat Oren; Haim Ashkenazy; Zohar Tiran; Amit Novik; Avi Rosenberg; Anat Amir; Assaf Wool; Amir Toporik; Ehud Schreiber; Dani Eshel; Zurit Levine; Yossi Cohen; Claudia A. Nold-Petry; Charles A. Dinarello; Itamar Borukhov

Blocking conformational changes in biologically active proteins holds therapeutic promise. Inspired by the susceptibility of viral entry to inhibition by synthetic peptides that block the formation of helix–helix interactions in viral envelope proteins, we developed a computational approach for predicting interacting helices. Using this approach, which combines correlated mutations analysis and Fourier transform, we designed peptides that target gp96 and clusterin, 2 secreted chaperones known to shift between inactive and active conformations. In human blood mononuclear cells, the gp96-derived peptide inhibited the production of TNFα, IL-1β, IL-6, and IL-8 induced by endotoxin by >80%. When injected into mice, the peptide reduced circulating levels of endotoxin-induced TNFα, IL-6, and IFNγ by >50%. The clusterin-derived peptide arrested proliferation of several neoplastic cell lines, and significantly enhanced the cytostatic activity of taxol in vitro and in a xenograft model of lung cancer. Also, the predicted mode of action of the active peptides was experimentally verified. Both peptides bound to their parent proteins, and their biological activity was abolished in the presence of the peptides corresponding to the counterpart helices. These data demonstrate a previously uncharacterized method for rational design of protein antagonists.


F1000Research | 2011

Peptides modulating conformational changes: From in silico design to in vivo proof of concept

Yossef Kliger; Ofer Levy; Anat Oren; Haim Ashkenazy; Zohar Tiran; Amit Novik; Avi Rosenberg; Anat Amir; Assaf Wool; Amir Toporik; Ehud Schreiber; Dani Eshel; Zurit Levine; Yossi Cohen; Claudia A. Nold-Petry; Charles A. Dinarello; Itamar Borukhov

From in-Silico Design to in-Vivo Proof of Concept Yossef Kliger, Ofer Levy, Anat Oren, Haim Ashkenazy, Zohar Tiran, Amit Novik, Avi Rosenberg, Anat Amir, Assaf Wool, Amir Toporik, Ehud Schreiber, Dani Eshel, Zurit Levine, Yossi Cohen, Claudia Nold-Petry, Charles A. Dinarello, Itamar Borukhov 1Compugen Ltd. Tel Aviv 69512, Israel. (www.cgen.com) *Correspondence: [email protected], [email protected] 2The Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel 3University of Colorado Denver, Aurora, CO 80045, USA


Archive | 2009

ANGIOPOIETIN DERIVED PEPTIDES

Yossef Kliger; Itamar Borukhov; Ofer Levy; Zohar Tiran; Assaf Wool; Ehud Schreiber; Anat Amir; Zurit Levine; Amir Toporik


Archive | 2009

NOVEL CLUSTERIN DERIVED PEPTIDE

Yossef Kliger; Ofer Levy; Itamar Borukhov; Assaf Wool; Ehud Schreiber; Anat Amir; Zurit Levine; Zohar Tiran; Anat Oren; Amir Toporik


Archive | 2009

NOVEL GP96 DERIVED PEPTIDES

Yossef Kliger; Ofer Levy; Itamar Borukhov; Anat Amir; Anat Oren


Archive | 2009

Novel angiopoietin derived peptides

Yossef Kliger; Itamar Borukhov; Ofer Levy; Zohar Tiran; Assaf Wool; Ehud Schreiber; Anat Amir; Zurit Levine; Amir Toporik


Archive | 2009

Von angiopoietin abgeleitete peptide

Yossef Kliger; Itamar Borukhov; Ofer Levy; Zohar Tiran; Assaf Wool; Ehud Schreiber; Anat Amir; Zurit Levine; Amir Toporik


Archive | 2009

Clusterin derived peptide

Yossef Kliger; Ofer Levy; Itamar Borukhov; Assaf Wool; Ehud Schreiber; Anat Amir; Zurit Levine; Zohar Tiran; Anat Oren; Amir Toporik


Archive | 2009

Nouveau peptide dérivé de clusterine

Yossef Kliger; Ofer Levy; Itamar Borukhov; Assaf Wool; Ehud Schreiber; Anat Amir; Zurit Levine; Zohar Tiran; Anat Oren; Amir Toporik


Archive | 2009

GP96 derived peptides

Yossef Kliger; Ofer Levy; Itamar Borukhov; Anat Amir; Anat Oren

Collaboration


Dive into the Anat Amir's collaboration.

Top Co-Authors

Avatar

Ofer Levy

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge